Tag: inspection

Inspection Observations Related to Poor Yield Reconciliation Practices

November 25, 2025November 25, 2025 digi

Inspection Observations Related to Poor Yield Reconciliation Practices Step-by-Step Guide to Managing Yield Calculations and Reconciliation in GMP In pharmaceutical manufacturing, yield calculations and reconciliation in GMP are critical processes ensuring that a product’s output aligns with expected quantities based on raw material inputs and processing parameters. Accurate yield data directly supports product quality assurance,…

Yield & Reconciliation

Inspection Findings on Inadequate Line Clearance and Product Mix-Ups

November 25, 2025November 25, 2025 digi

Inspection Findings on Inadequate Line Clearance and Product Mix-Ups Step-by-Step Guide to Effective Line Clearance in Pharmaceutical Manufacturing Line clearance in pharmaceutical manufacturing is an essential control measure designed to prevent product mix-ups, contamination, and cross-contamination. Regulatory authorities such as the FDA, EMA, and MHRA consistently identify inadequate line clearance as a critical deficiency during…

Line Clearance

Inspection Findings on Weak CAPA and Deviation Handling in QC Labs

November 25, 2025November 25, 2025 digi

Inspection Findings on Weak CAPA and Deviation Handling in QC Labs Step-by-Step Tutorial Guide on Managing QC Laboratory Deviations and CAPA Effective management of qc laboratory deviations and capa is a critical component of pharmaceutical Good Manufacturing Practice (GMP) compliance. Inspection authorities including the FDA, EMA, MHRA, and PIC/S routinely identify deficiencies in the handling…

QC Deviations & CAPA

Top QC Laboratory Findings in FDA and EU Inspections

November 25, 2025November 25, 2025 digi

Top QC Laboratory Findings in FDA and EU Inspections Comprehensive Step-by-Step Guide to QC Laboratory Findings and Remediation in FDA and EU Inspections Quality Control (QC) laboratories are critical to ensuring pharmaceutical product quality, safety, and compliance. Regulatory inspections by agencies such as the FDA, EMA, and MHRA identify specific common findings in QC labs…

QC Lab Audits

Inspection Observations Related to Poor Handling of Compendial Methods

November 25, 2025November 25, 2025 digi

Inspection Observations Related to Poor Handling of Compendial Methods Addressing Inspection Observations: Proper Validation and Verification of Compendial Methods Pharmaceutical companies operating in the United States, United Kingdom, and European Union must rigorously adhere to Good Manufacturing Practice (GMP) regulations concerning compendial methods used in quality control laboratories. Regulatory inspections frequently identify deviations related to…

Compendial Methods

Inspection Focus on QC Results Review and Second Person Checks

November 25, 2025November 25, 2025 digi

Inspection Focus on QC Results Review and Second Person Checks Effective QC Results Review and Approval: A Step-by-Step Pharmaceutical GMP Tutorial Quality Control (QC) results review and approval remain a pivotal element of pharmaceutical Good Manufacturing Practice (GMP). Regulatory agencies such as the FDA, EMA, MHRA, and PIC/S emphasize rigorous qc results review and approval…

Results Review

Audit Findings on Poor QC Documentation Practices

November 25, 2025November 25, 2025 digi

Audit Findings on Poor QC Documentation Practices: A Step-by-Step GMP Tutorial Effective Management of QC Laboratory Documentation Raw Data Worksheets: A Step-by-Step GMP Tutorial In pharmaceutical manufacturing, QC laboratory documentation raw data worksheets are critical components of the quality management system. Proper documentation ensures compliance with regulatory requirements from agencies such as the FDA, EMA,…

QC Documentation

Inspection Experiences: Environmental Monitoring Gaps in QC Laboratories

November 25, 2025 digi

Inspection Experiences: Environmental Monitoring Gaps in QC Laboratories How to Identify and Address Environmental Monitoring Gaps in QC Laboratories: A Step-by-Step Tutorial The environmental monitoring program for QC laboratories is a critical component of pharmaceutical Good Manufacturing Practice (GMP) compliance. Regulatory authorities across the US, UK, and EU, including the FDA, EMA, MHRA, and PIC/S,…

Environmental Monitoring

Inspection Findings Related to Microbiology QC Laboratory Deficiencies

November 25, 2025November 25, 2025 digi

Inspection Findings Related to Microbiology QC Laboratory Deficiencies Step-by-Step Guide to Understanding and Addressing Microbiology QC Laboratory Deficiencies Microbiology QC laboratory controls are a critical element in pharmaceutical manufacturing quality assurance. These controls ensure that microbiological testing accurately reflects product safety, sterility, and compliance with regulatory standards across US, UK, and EU jurisdictions. However, microbiology…

Microbiology QC

Inspection Findings Related to Microbiology QC Laboratory Deficiencies

November 25, 2025November 25, 2025 digi

Inspection Findings Related to Microbiology QC Laboratory Deficiencies Step-by-Step Guide to Understanding and Addressing Microbiology QC Laboratory Deficiencies Microbiology QC laboratory controls are critical elements in ensuring pharmaceutical product quality, safety, and compliance with Good Manufacturing Practices (GMP). Regulatory authorities such as the FDA, EMA, MHRA, PIC/S, and WHO frequently identify deficiencies related to microbiology…

Microbiology QC